Positioning no disclosures inside 60 days, left as found
Options put/call open interest 4.91, read 2026-11-05
Ethical passes the values gate
Price7.71 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-09-13Read Markdown12.02-35.9% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-08-13Read Distribution12.14-36.5% to today ✓Markup gives way to Distribution after a 33% slide in 6 weeks
2026-07-02Read Markup18.23-57.7% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Spire Global, Inc. holds its Markdown at $7.71. The statistical read favours the sellers, held for 82 days.
As held on the ledger · 2026-11-05
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 82 days
Price at the screen
$7.71
Valuation
N/A trailing · -19.77 forward price to earnings
Values screen
PASS· score 70.0
Beta
3.17
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
6.35%
Below 33%
Interest-bearing debt is just 6.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
27.00%
Below 33%
Cash held in interest-bearing accounts and securities is 27.0% of assets, under the one-third limit.
Pass
Receivables
13.74%
Below 49%
Money owed to the company is 13.7% of assets, under the 49% limit.
Pass
Revenue purity
3.40%
Below 5%
Only 3.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Spire Global, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and interest is about 3% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SPIR's ethical verdict changes
Today SPIR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.89x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SPIR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$8.70-0.7%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-10-28Markdown$8.76-5.8%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-10-21Markdown$9.30-9.4%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-10-14Markdown$10.27-14.1%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 103% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-10-02Markdown$11.96-0.5%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 103% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-09-13Markdown · changed$12.02-1.0%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 103% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 33.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 103% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-07-18Markup$18.23+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 103% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (4 analysts) rates it strong buy, with a mean price target of $20.
2026-07-03Markup$18.23+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$18.23Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.